Bevacizumab in metastatic colorectal cancer: A left intracardiac thrombotic event [6]

Annals of Oncology

Volumn 17, Issue 7, 2006, Pages 1177-1178

  Roncalli, J ^a   Delord, J P ^b   Galinier, M ^a   Massabuau, P ^a   Lescure, M ^c   Fauvel, J M ^a   Azria, D ^d  

^a CHU RANGUEIL   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c General Hospital   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BEVACIZUMAB; FLUOROURACIL; HEPARIN; OXALIPLATIN;

ADULT; ANGIOCARDIOGRAPHY; CANCER GROWTH; CASE REPORT; COLORECTAL CANCER; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE NECROSIS; HEART TUMOR; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTRACARDIAC THROMBOSIS; LETTER; METASTASIS POTENTIAL; PATIENT REFERRAL; PRIORITY JOURNAL; RESUSCITATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMANS; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745585559     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl025     Document Type: Letter

References (5)

1. Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-181.
2. Kilickap S, Abali H, Celik I. Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol 2003; 21: 3542.
3. Skillings JR, Johnson DH, Miller K et al. Arterial thromboembolic events (ATEs) in a pooled analysis of 5 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy. J Clin Oncol 2005; 24: (Abstr 3019).
4. Motl S. Bevacizumab in combination chemotherapy for colorectal and other cancers. Am J Health Syst Pharm 2005; 62: 1021-1032.
5. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342